A proposed merger

Arrow and Apotex have announced a proposed merger of their Australian and New Zealand generic pharmaceutical and OTC operations The proposed merger between Arrow Pharmaceuticals and Apotex is still subject to several conditions, including ACCC approval and due diligence, and is anticipated for completion in the new financial year. According to a statement released late Wednesday

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Funding reduced for top medicine bodies
Next Duckett condemns 'do-nothing response' to King Review